These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 8826578)

  • 1. Costs of therapeutic alternatives: physicians' knowledge.
    Griswold MW; Briceland LL; Lesar TS
    Ann Pharmacother; 1996; 30(7-8):882-3. PubMed ID: 8826578
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of cholesterol-lowering medications in the United States from 1991 to 1997.
    Siegel D; Lopez J; Meier J
    Am J Med; 2000 Apr; 108(6):496-9. PubMed ID: 10781783
    [No Abstract]   [Full Text] [Related]  

  • 3. Interpreting and analysing practice prescribing data.
    Nicholls J
    Community Nurse; 2000 Jul; 6(6):39-42. PubMed ID: 12778649
    [No Abstract]   [Full Text] [Related]  

  • 4. Prescribing costs and patterns: authors' response.
    Walker J; Mathers N
    Br J Gen Pract; 2002 Jul; 52(480):587. PubMed ID: 12120741
    [No Abstract]   [Full Text] [Related]  

  • 5. Update on Psychotropic Drug Prescribing in the United States: 2014-2015.
    Greenblatt DJ; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 2018 Feb; 38(1):1-4. PubMed ID: 29215384
    [No Abstract]   [Full Text] [Related]  

  • 6. Prescribing and drug costs in the province of Ontario.
    Lexchin J
    Int J Health Serv; 1992; 22(3):471-87. PubMed ID: 1644510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing.
    Palmer K
    Practitioner; 1990 Oct; 234(1495):888-90. PubMed ID: 2131447
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluating prescribing interventions.
    Wong G
    Br J Gen Pract; 2002 May; 52(478):412-3. PubMed ID: 12014546
    [No Abstract]   [Full Text] [Related]  

  • 9. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds.
    McCarthy M
    BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964
    [No Abstract]   [Full Text] [Related]  

  • 10. Students and Doctors are Unaware of the Cost of Drugs they Frequently Prescribe.
    Schutte T; Tichelaar J; Nanayakkara P; Richir M; van Agtmael M
    Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):278-283. PubMed ID: 27639184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey.
    Watkins C; Harvey I; Carthy P; Moore L; Robinson E; Brawn R
    Qual Saf Health Care; 2003 Feb; 12(1):29-34. PubMed ID: 12571342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do drug costs affect physicians' prescription decisions?
    Hart J; Salman H; Bergman M; Neuman V; Rudniki C; Gilenberg D; Matalon A; Djaldetti M
    J Intern Med; 1997 May; 241(5):415-20. PubMed ID: 9183310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing.
    Prosser H; Walley T
    Soc Sci Med; 2005 Mar; 60(6):1335-46. PubMed ID: 15626528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rising prescription drug costs: whose responsibility?
    Hill SR; Henry DD; Smith AJ
    Med J Aust; 1997 Jul; 167(1):6-7. PubMed ID: 9236749
    [No Abstract]   [Full Text] [Related]  

  • 15. Physicians. Profiling in practice.
    Montague J
    Hosp Health Netw; 1994 Jan; 68(2):50-1. PubMed ID: 8275129
    [No Abstract]   [Full Text] [Related]  

  • 16. Determinants of prescribing costs amongst single-handed general practitioners.
    Gill PS; Roalfe A
    J Clin Pharm Ther; 2001 Dec; 26(6):433-5. PubMed ID: 11722680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
    Gurwitz JH; McLaughlin TJ; Fish LS
    Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urban-rural inequality regarding drug prescriptions in primary care facilities - a pre-post comparison of the National Essential Medicines Scheme of China.
    Yao Q; Liu C; Ferrier JA; Liu Z; Sun J
    Int J Equity Health; 2015 Jul; 14():58. PubMed ID: 26219841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the appropriateness of physician prescribing.
    Lexchin J
    Int J Health Serv; 1998; 28(2):253-67. PubMed ID: 9595343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunity and Equity Costs of Multilevel Adaptive Interventions to Reduce Opioid Prescribing.
    Alderson SL
    JAMA Netw Open; 2024 Oct; 7(10):e2438335. PubMed ID: 39388185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.